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INTRODUCTION
Calcium pyrophosphate dihydrate (CPPD) crystal deposi-
tion disease is characterized by the deposition of CPPD crys-
tals in the articular cartilage visualized as intra-articular cal-
cifications (chondrocalcinosis), identification of the crystals in
the synovial fluid, and acute arthropathy (1). Radiographic
surveys show an age-related increase of chondrocalcinosis and
by the ninth decade almost 50% of individuals have chondro-
calcinosis (2). However, the prevalence of chondrocalcinosis or
CPPD crystal deposition disease is not known in Korea. The
gender distribution of CPPD crystal deposition disease has
differed among large studies (3, 4). The manifestations of
CPPD crystal deposition disease include incidental finding
of chondrocalcinosis, acute attack of arthritis (pseudogout),
and chronic arthritis. The knee is the most commonly involved
joint, followed by the wrist, metacarpophalangeal, hips, shoul-
der, and ankle joints (5).
In young patients who are under 40 yr old, chondrocalci-
nosis is an unusual finding. Chondrocalcinosis in young age is
known to be associated with a variety of endocrine and metabol-
ic conditions (6). If the patient is younger than 55 yr, it is rea-
sonable to search for metabolic causes. There are five or fewer
case reports about CPPD crystal deposition disease in Korea
and all these cases developed in old age (7-11). The number
of case reports on the idiopathic CPPD crystal deposit disease
in young individuals is notably limited (12, 13) and in Korea
no such cases have been reported in the literature. Thus, we
report the first case of a young male patient who presented
with idiopathic CPPD crystal deposition disease at the age
of 29 yr.
CASE REPORT
A 29-yr-old male patient was admitted to the orthopedic
ward of our hospital because of recurrent swelling, stiffness,
and severe pain involving the right knee in 2001. Arthroscop-
ic synovectomy and irrigation for the right knee joint was done
due to recurrent, progressive episodic events. After that, the
rheumatologists were consulted because of chondrocalcinosis
of both knee joints on plain radiography. He first developed
pain and swelling on the right knee after falling down during
skiing back in 1998. He had experienced recurrent swelling,
severe pain in both knees occurring three or four times a year,
and had been treated symptomatically. Acute attacks of arthri-
tis of both knee joints were self-limiting and resolved usually
within 2-3 weeks. Other joints were asymptomatic. He had
no family history of joint diseases. On examination, there was
swelling, painful restriction of movement in his right knee
Joong Kyung Ahn, Hyung Jin Kim,
Eung Ho Kim, Chan Hong Jeon,
Hoon-Suk Cha, Chul Won Ha*,
Joong Mo Ahn
� , Eun-Mi Koh
Departments of Medicine, Orthopedic Surgery*
and Radiology
� , Samsung Medical Center,
Sungkyunkwan University School of Medicine,
Seoul, Korea
Address for correspondence
Eun-Mi Koh, M.D.
Department of Medicine, Samsung Medical Center,
Sungkyunkwan University School of Medicine, 50
Ilwon-dong, Gangnam-gu, Seoul 135-230, Korea
Tel : +82.2-3410-3439, Fax : +82.2-3410-3849
E-mail : debate@empal.com
917
J Korean Med Sci 2003; 18: 917-20
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
Idiopathic Calcium Pyrophosphate Dihydrate (CPPD) Crystal
Deposition Disease in a Young Male Patient
: A Case Report
Calcium pyrophosphate dihydrate (CPPD) crystal deposition disease is a disease of
the elderly and extremely rare in young individuals. If young people develop CPPD
crystal deposition disease, it may be associated with metabolic diseases such as
hemochromatosis, hyperparathyroidism, hypophosphatasia, hypomagnesemia, Wil-
son’ s disease, hypothyroidism, gout, acromegaly, and X-linked hypophosphatemic
rickets. Therefore, in young-onset polyarticular CPPD crystal deposition disease,
investigation for predisposing metabolic conditions is warranted. We report a case
of a young male patient with idiopathic CPPD crystal deposition disease, who did
not have any evidences of metabolic diseases after thorough evaluations. As far as
we know, this is the first report of a young male patient presented with idiopathic
CPPD crystal deposition disease.
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joint. The right elbow joint had a limited range of motion to
that of 90 degrees due to dislocation as an adolescent. Other
examinations were unremarkable. Radiographic studies of the
affected knee joint revealed typical articular chondrocalcinosis
in such areas as the retropatellar cartilage, the medial and lat-
eral menisci with narrowing of the joint space in the patel-
lofemoral compartment (Fig. 1). Calcification was noted even
in asymptomatic joints such as chondral cartilage of the prox-
imal humerus of both shoulders and the symphysis pubis in
plain radiographs (Fig. 2, 3). Moreover, radiographs of both
wrists showed chondrocalcinosis of the triangular fibrocarti-
lage of the wrist. To differentiate metabolic conditions asso-
ciated with CPPD deposition, the evaluation included calci-
um, phosphorous, alkaline phosphatase, thyroid function test,
iron and copper studies, as well as liver MRI. Laboratory inves-
tigations showed a white cell count of 8,600/ L, hemoglobin
14.6 g/dL, platelet 281,000/ L, Na+/K+/Cl- 139/3.9/99
mmol/L, calcium/phosphate 9.4/3.8 mg/dL, Mg++ 2.1 mg/
dL, uric acid 5.1 mg/dL, ESR 4 mm/hr (Westergren method),
CRP 1.65 mg/dL, ALP 105 U/L, Fe 2.1  g/dL, TIBC 318  g/
dL (normal range: 250-425  g/dL), ferritin 182.1 ng/mL,
ceruloplasmin 31.6 mg/dL (normal range 25-63 mg/dL), 24
hr urine copper 41  g/day (reference range <38  g/day), 24
hr urine Fe 46.5  g/day (normal range 100-300  g/day), T3
by RIA 113 ng/dL, T4 by RIA 9.3  g/dL, TSH 1.4  IU/
mL and intact PTH 12.9 pg/mL. Findings of liver MRI were
normal. We could not find a metabolic disorder predispos-
ing the young patient to CPPD crystal deposition.
A biopsy of the synovium showed chronic synovitis with
villous hypertrophy. Intracellular calcium pyrophosphate crys-
tals were not observed in aspirated synovial fluid and synovi-
um under compensated polarized microscope. However, this
patient’ s clinical and radiologic findings satisfied the possi-
ble diagnosis for idiopathic CPPD crystal deposition disease,
that is, recurrent, acute, self-limiting synovitis, and chon-
drocalcinosis of target joints such as knee, shoulder, wrist, and
symphysis pubis (3). He was treated with naproxen (1 g/day)
and is now on follow-up without recurrence of symptoms.
Fig. 1. Radiographs of the anterior-posterior views of right knees
showing linear calcifications in the areas of the medial and lateral
menisci of the knee, consistent with chondrocalcinosis (arrow).
Fig. 3. A radiograph of the right shoulder showing calcification in
the chondral cartilage of the proximal humerus.
Fig. 2. A radiograph of the pelvis showing typical articular chondro-
calcinosis of the symphysis pubis and both hip joints.CPPD in a Young Patient 919
DISCUSSION
CPPD is a calcium salt that is deposited in hyaline and
fibrocartilage, appearing as chondrocalcinosis on radiologic
finding (14). The exact mechanism of CPPD crystals depo-
sition in joints is not completely understood. CPPD crystal
deposition may be influenced by the elevated level of inorgan-
ic pyrophosphate (PPi) in joints (6, 15). CPPD crystal depo-
sition may be an incidental finding, or may be associated with
severe clinical symptoms including arthritis (6). Asymptomat-
ic chondrocalcinosis is the most common clinical finding of
CPPD deposition. CPPD can also be released as a crystal into
a joint, causing acute painful arthritis called pseudogout.
Symptoms of acute pseudogout closely resemble those of any
acute arthritis including gout and infection. Even though the
presentation of pseudogout is similar to that of gout, attacks
of pseudogout tend to be less painful and take longer to reach
peak intensity than gout. Large joints are affected more com-
monly than small joints (14). The joints most commonly in-
volved in an acute attack differ between gout and pseudogout.
Almost half of all acute attacks of pseudogout involve the
knees, although nearly all joints may be affected.
The diagnosis of CPPD crystal deposition diseases is largely
based on the presence of positively birefringent intracellular
CPPD crystals and/or typical cartilage or joint capsule chon-
drocalcinosis on radiographic finding. In contrast to monosodi-
um urate crystals in acute gouty arthritis, CPPD crystals are
more difficult to detect because of the smaller size and only weak
or no positive birefringence. As in the present case, CPPD
crystal in chronic arthritis may be only intermittently present
on serial synovial fluid samplings (5). In addition, CPPD crys-
tal may not be seen in joint samples because joint tissues were
smashed to piece under arthroscopy. The managements in
general include analgesics and NSAID, physiotherapy, intra-
articular injection, and surgery, although the optimal treat-
ment has not been established.
According to the presence or absence of recognized predis-
posing factors, arthritis associated with CPPD crystal depo-
sition is classified as hereditary, idiopathic (sporadic), or asso-
ciated with various metabolic diseases or trauma. Most cases
of CPPD deposition disease are idiopathic. Advanced age is
the most common risk factor for the development of CPPD
crystal-associated arthritis. CPPD crystal deposition disease,
although very rare in young adults, can occur in some young
patients if there is a history of an injury to or an operation
performed on a joint, or if there is a family history of the dis-
ease, or the individual has other diseases that may increase the
susceptibility to CPPD crystal deposition disease. Most patients
with the familial disease show an autosomal dominant inher-
itance (5). It has been reported that chondrocalcinosis can occur
in a young athlete, possibly after repetitive joint insult (16).
Trauma-induced chondrocalcinosis tends to be monoarticu-
lar, involving the traumatized joint. In the present case, the
patient had neither a family history nor a past or present repet-
itive trauma history associated with CPPD crystal deposition
disease.
A variety of metabolic and endocrine disorders are associat-
ed with the illness, particularly among young patients. Hemo-
chromatosis is the only disease clearly associated with the
CPPD crystal-related joint disease (17, 18). Other rare metabol-
ic diseases that predispose the patients to CPPD deposition
include hyperparathyroidism (19), hypophosphatasia (20),
hypomagnesemia (21), Wilson’ s disease (22), hypothyroidism
(22, 23), acromegaly, and X-linked hypophosphatemic rick-
ets (18).
In general, associated metabolic diseases and familial pre-
disposition are rarely identified in CPPD deposition disease
(24) and routine screening for hereditary or metabolic diseases
is not warranted in all CPPD patients. However, further inves-
tigation for the predisposing metabolic condition is warrant-
ed in young-onset polyarticular chondrocalcinosis (2) because
CPPD crystal deposition disease may sometimes be an impor-
tant clue for detecting other treatable and preventable condi-
tions. Also, screening of asymptomatic family members is
important since life-threatening complications can be avoided
by instituting appropriate treatments if hemochromatosis,
hypomagnesemia, or hypophosphatasia are confirmed (17).
In summary, we report an unusual case of CPPD deposi-
tion disease in a young patient who did not have any predis-
posing or associated disease or hereditary causes. We believe
this is the first case of such disease in Korea.
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